Volume | 22,718 |
|
|||||
News | - | ||||||
Day High | 2.30 | Low High |
|||||
Day Low | 2.22 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Check Cap Ltd | CHEK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.22 | 2.22 | 2.30 | 2.285 | 2.27 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
176 | 22,718 | $ 2.27 | $ 51,561 | - | 1.27 - 4.625 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:30:14 | 1 | $ 2.37 | USD |
Check Cap Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
13.34M | 5.85M | - | 0 | -19.11M | -3.27 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Check Cap News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CHEK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.26 | 2.31 | 2.19 | 2.26 | 30,318 | 0.025 | 1.11% |
1 Month | 3.10 | 3.10 | 2.12 | 2.46 | 45,097 | -0.815 | -26.29% |
3 Months | 2.20 | 3.45 | 1.78 | 2.48 | 272,274 | 0.085 | 3.86% |
6 Months | 3.33 | 3.937 | 1.78 | 2.49 | 138,026 | -1.05 | -31.38% |
1 Year | 1.31 | 4.625 | 1.27 | 2.65 | 112,393 | 0.975 | 74.43% |
3 Years | 31.40 | 38.178 | 1.22 | 17.61 | 713,587 | -29.12 | -92.72% |
5 Years | 52.20 | 89.80 | 1.22 | 29.58 | 2,238,665 | -49.92 | -95.62% |
Check Cap Description
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. |